Matthias Diebold

7PUBLICATIONS
29CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Preventative health careAutonomic nervous systemCarbon sequestration science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2025
Antibody-mediated rejection-treatment standard.

Georg A Böhmig, Maarten Naesens, Ondrej Viklicky

|Apr 29, 2025
Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.

Matthias Diebold, Patrick T Gauthier, Katharina A Mayer

|Feb 25, 2025
Breaking barriers: giving HOPE to people living with HIV and end-stage renal disease.

Matthias Diebold, Adnan Sharif

|Jun 07, 2022
Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure.

Tobias Breidthardt, William P T M van Doorn, Noreen van der Linden

|Apr 25, 2022
International Validation of the Canadian Syncope Risk Score : A Cohort Study.

Tobias Zimmermann, Jeanne du Fay de Lavallaz, Thomas Nestelberger

|Jun 02, 2021
Comparison of Acute Kidney Injury in Patients with COVID-19 and Other Respiratory Infections: A Prospective Cohort Study.

Matthias Diebold, Tobias Zimmermann, Michael Dickenmann

Pageof 2

Frequent Collaborators

3 joint publications

Tobias Zimmermann

2 joint publications

Klemens Budde

2 joint publications

Christian Mueller

2 joint publications

Tobias Breidthardt